Healthway Medical Corporation Limited reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported revenue of SGD 23,188,000 against SGD 24,059,000 a year ago. Loss before income tax was SGD 64,000 against Profit of SGD 1 2,474,000 a year ago. Profit attributable to shareholders was SGD 55,000 against SGD 2,049,000 a year ago. Net cash generated from operating activities was SGD 1,753,000 against SGD 4,337,000 a year ago. Addition to of property, plant and equipment was SGD 202,000 against SGD 474,000 a year ago. The decrease was mainly due to decrease in revenue from the Primary Healthcare segment. Operating income decreased was mainly due to absence in fiscal year 2016 second quarter of SGD 1.1 million for the recovery of staff costs for secondment fees from third party clinics managed by the Group, a decrease in fiscal year 2016 second quarter of SGD 0.6 million interest income and a foreign exchange loss of SGD 0.5 million in fiscal year 2016 second quarter SGD 0.3 million. For the six months, the company reported revenue of SGD 47,888,000 against SGD 47,738,000 a year ago. Profit before income tax was SGD 626,000 against SGD 6,620,000 a year ago. Profit attributable to shareholders was SGD 635,000 or 0.03 cents per basic and diluted share against SGD 5,566,000 or 0.24 cents per basic and diluted share a year ago. Net cash generated from operating activities was SGD 5,326,000 against SGD 7,777,000 a year ago. Purchase of property, plant and equipment was SGD 245,000 against SGD 580,000 last year.